|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9360
|
|
pubmed:dateCreated |
2003-3-18
|
|
pubmed:abstractText |
Japanese encephalitis virus (JEV), although confined to Asia, causes about 35000-50000 cases and 10000 deaths every year, and is the most important cause of encephalitis worldwide. There is no known antiviral treatment for any flavivirus. Results from in-vitro studies and work in animals have shown inteferon alfa has antiviral activity on Japanese encephalitis and other flaviviruses; therefore, we aimed to assess the efficacy of inteferon alfa-2a in Japanese encephalitis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
pubmed-author:DietTran VinhTV,
pubmed-author:DungNguyen MinhNM,
pubmed-author:FarrarJeremy JJJ,
pubmed-author:GainsboroughMaryM,
pubmed-author:KhanhVo CongVC,
pubmed-author:KneenRachelR,
pubmed-author:LoanHa ThiHT,
pubmed-author:SolomonTomT,
pubmed-author:ThuyTran Thi NhuTT,
pubmed-author:VaughnDavid WDW,
pubmed-author:WhiteNicholas JNJ,
pubmed-author:WillsBridgetB
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
8
|
|
pubmed:volume |
361
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
821-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12642049-Adolescent,
pubmed-meshheading:12642049-Antiviral Agents,
pubmed-meshheading:12642049-Child,
pubmed-meshheading:12642049-Child, Preschool,
pubmed-meshheading:12642049-Double-Blind Method,
pubmed-meshheading:12642049-Encephalitis, Japanese,
pubmed-meshheading:12642049-Female,
pubmed-meshheading:12642049-Humans,
pubmed-meshheading:12642049-Infant,
pubmed-meshheading:12642049-Interferon-alpha,
pubmed-meshheading:12642049-Male,
pubmed-meshheading:12642049-Recombinant Proteins,
pubmed-meshheading:12642049-Treatment Failure,
pubmed-meshheading:12642049-Vietnam
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.
|
|
pubmed:affiliation |
Department of Neurological Science, University of Liverpool, Walton Centre for Neurology and Neurosurgery, Liverpool, UK. tsolomon@liv.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
